Autoantibodies and High-Risk HLA Susceptibility Markers in First-Degree Relatives of Brazilian Patients with Type 1 Diabetes Mellitus: A Progression to Disease Based Study (2012)
- Authors:
- USP affiliated authors: ROCHA, DALVA MARREIRO - FM ; FUKUI, ROSA TSUNECHIRO - FM
- Unidade: FM
- DOI: 10.1007/s10875-012-9673-4
- Subjects: AUTOANTICORPOS; DIABETES MELLITUS INSULINO-DEPENDENTE; BIOMARCADORES
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Journal of Clinical Immunology
- ISSN: 0271-9142
- Volume/Número/Paginação/Ano: v. 32, n. 4, p. 778-785, 2012
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
ALVES, L. I. et al. Autoantibodies and High-Risk HLA Susceptibility Markers in First-Degree Relatives of Brazilian Patients with Type 1 Diabetes Mellitus: A Progression to Disease Based Study. Journal of Clinical Immunology, v. 32, n. 4, p. 778-785, 2012Tradução . . Disponível em: http://link.springer.com/article/10.1007/s10875-012-9673-4. Acesso em: 19 abr. 2024. -
APA
Alves, L. I., Davini, E., Correia, M. R., Fukui, R. T., Santos, R. F., Cunha, M. R., et al. (2012). Autoantibodies and High-Risk HLA Susceptibility Markers in First-Degree Relatives of Brazilian Patients with Type 1 Diabetes Mellitus: A Progression to Disease Based Study. Journal of Clinical Immunology, 32( 4), 778-785. doi:10.1007/s10875-012-9673-4 -
NLM
Alves LI, Davini E, Correia MR, Fukui RT, Santos RF, Cunha MR, Rocha DM, Volpini WMG, Silva MER. Autoantibodies and High-Risk HLA Susceptibility Markers in First-Degree Relatives of Brazilian Patients with Type 1 Diabetes Mellitus: A Progression to Disease Based Study [Internet]. Journal of Clinical Immunology. 2012 ; 32( 4): 778-785.[citado 2024 abr. 19 ] Available from: http://link.springer.com/article/10.1007/s10875-012-9673-4 -
Vancouver
Alves LI, Davini E, Correia MR, Fukui RT, Santos RF, Cunha MR, Rocha DM, Volpini WMG, Silva MER. Autoantibodies and High-Risk HLA Susceptibility Markers in First-Degree Relatives of Brazilian Patients with Type 1 Diabetes Mellitus: A Progression to Disease Based Study [Internet]. Journal of Clinical Immunology. 2012 ; 32( 4): 778-785.[citado 2024 abr. 19 ] Available from: http://link.springer.com/article/10.1007/s10875-012-9673-4 - Auto-anticorpos não pancreáticos: prevalencia e associação com HLA-DR/DQ, alelos de classe I do VNTR e CTLA4 em diabetes tipo 1A em pacientes brasileiros
- Analisys of the distribuition of class I and II VNTR alleles of the insulin gene linked minisatellite locus in type 1 diabetes mellitus in Brazil
- Insulin (IAA), Glutamic Acid Decarboxilase-65 (antiGAD) and Tirosine-Fosfatase (anti-IA2) Autoantibodies (AB): Prevalence and Associations with HLA-DR Haplotypes, Insulin VNTR and CTLA4 alleles in siblings of type i diabetes (DM1) Patients
- Non-Islet Autoantibodies (Non-IsletAAb): Prevalence and Association with PTPN22 1858T in Brazilian Type I Diabetes Mellitus (DMI) Patients
- Insulin (IAA), glutamic acid decarboxylase-65 (antigad) and tyrosine-phosphatase (anti-IA2) autoantibodies: prevalence and association with hla-dr haplotypes, ins vntr, and ctla4 in siblings of patients with type 1 diabetes in Brazil
- Sitagliptin versus bedtime NPH insulin as thirdline anti-hyperglycemic agent in type 2 Diabetes Melittus (DM2) treatment
- Effects of nateglinide and rosiglitazone on pancreatic alpha- and beta-cells, GLP-1 secretion and inflammatory markers in patients with type 2 diabetes: randomized crossover clinical study
- Efeitos benéficos da associação de rosiglitazona ou metformina à glibenclamida no controle Glicêmico e risco cardiovascular
- Genetic Association of the Lymphoid Tyrosine Phosphatase Locus (LYP/PTPN22) and Type 1 Diabetes in Brazil
- Resposta terapêutica ao uso de rosiglitazona ou nateglinida em diabéticos do tipo 2.
Informações sobre o DOI: 10.1007/s10875-012-9673-4 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
